Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VEEV · against 1,372 other Healthcare companies
Ranked #375 of 1,373 · scores higher than 73% of peers · safety percentile 73
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 70–79, including VEEV · Click a bar to see the companies
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VEEV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.02× | 0.24× | 84% | 33% | |
| BetaLower is better · 1,320 reported | 0.97 | 0.53 | 25% | 33% | |
| Current ratioHigher is better · 1,338 reported | 5.46× | 2.62× | 76% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 371 | 264M USD | 73 | 30 | |
| 372 | 13.3B CNY (≈$1.9B) | 73 | 49 | |
| 373 | 626.0B INR (≈$7.5B) | 73 | 68 | |
| 374 | 2.3B USD | 73 | 27 | |
| 375 | 49.1B USD | 73 | 69 | |
| 376 | 225.2B CNY (≈$31.5B) | 73 | 63 | |
| 377 | 32.35T IDR (≈$2.0B) | 73 | 76 | |
| 378 | 143.9B JPY (≈$978M) | 73 | 26 | |
| 379 | 5.7B HKD (≈$725M) | 72 | 58 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score